Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07769502 |
| Title | A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Roswell Park Cancer Institute /ID# 284461 | Buffalo | New York | 14263 | United States | Details | |
| McGill University Health Centre - Glen Site /ID# 285570 | Montreal | Quebec | H4A 3J1 | Canada | Details | |
| Cancer Hospital - Chinese Academy of Medical Sciences /ID# 281737 | Beijing | Beijing Municipality | 100021 | China | Details | |
| West China Hospital of Sichuan University /ID# 281734 | Chengdu | Sichuan | 610041 | China | Details |